| P50 | author | Irene Cózar-Castellano | Q59315250 |
| | Margarita Jiménez-Palomares | Q83638064 |
| | Sara Molina-Gil | Q96140506 |
| | Oscar Ortiz-Barajas | Q114336645 |
| | Monica Garcia-Alloza | Q42243268 |
| | Juan Jose Ramos-Rodriguez | Q46687294 |
| | Alfonso Maria Lechuga-Sancho | Q46687316 |
| | German Perdomo | Q47504458 |
| P2860 | cites work | Association of diabetes mellitus and dementia: the Rotterdam Study. | Q50989914 |
| | Hyperinsulinemia and risk of Alzheimer disease. | Q51526824 |
| | GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid | Q81242039 |
| | Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain | Q83396445 |
| | Early exposure to a high-fat diet has more drastic consequences on metabolism compared with exposure during adulthood in rats | Q83720231 |
| | Brain structure and obesity | Q24644378 |
| | Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease | Q27021700 |
| | Adult mice maintained on a high-fat diet exhibit object location memory deficits and reduced hippocampal SIRT1 gene expression | Q30453017 |
| | Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes | Q33859600 |
| | Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome. | Q34031315 |
| | Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons | Q34083053 |
| | Increased hippocampal neurogenesis in Alzheimer's disease. | Q34281877 |
| | Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study | Q34458197 |
| | FTY720 normalizes hyperglycemia by stimulating β-cell in vivo regeneration in db/db mice through regulation of cyclin D3 and p57(KIP2). | Q35774014 |
| | An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers | Q35858008 |
| | Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis | Q35960169 |
| | Insulin resistance in the nervous system | Q36084516 |
| | Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes | Q36087568 |
| | Leptin action on nonneuronal cells in the CNS: potential clinical applications | Q36124118 |
| | The insulin regulatory network in adult hippocampus and pancreatic endocrine system | Q36231289 |
| | Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease | Q36577266 |
| | The adverse impact of type 2 diabetes on brain volume in heart failure | Q36786697 |
| | Insulin and ghrelin: peripheral hormones modulating memory and hippocampal function | Q37006359 |
| | Impaired neurogenesis in adult type-2 diabetic rats | Q37114319 |
| | The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged | Q37280580 |
| | Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice | Q37295166 |
| | Adult hippocampal neurogenesis in aging and Alzheimer's disease. | Q37823486 |
| | Dementia, diabetes, Alzheimer's disease, and insulin resistance in the brain: progress, dilemmas, new opportunities, and a hypothesis to tackle intersecting epidemics. | Q37845040 |
| | Insulin resistance in the brain: an old-age or new-age problem? | Q38013489 |
| | Mechanisms of diabetic complications. | Q38072902 |
| | Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling | Q38297889 |
| | Rapid β-amyloid deposition and cognitive impairment after cholinergic denervation in APP/PS1 mice | Q39460000 |
| | Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin | Q41882101 |
| | High-fat diet ameliorates neurological deficits caused by defective astrocyte lipid metabolism | Q41933641 |
| | Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes. | Q42668655 |
| | Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. | Q42950655 |
| | Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease | Q43207399 |
| | Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2. | Q43260001 |
| | Cortical neurogenesis in adult rats after transient middle cerebral artery occlusion | Q43599424 |
| | Neuroprotective actions of leptin on central and peripheral neurons in vitro. | Q43791966 |
| | Cerebral cortical thickness in patients with type 2 diabetes | Q46177073 |
| | A high fat diet does not exacerbate CA1 injury and cognitive deficits following global ischemia in rats. | Q46205478 |
| | Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice. | Q46396191 |
| | Impaired proliferation of non-parenchymal cells participates in an impairment of liver regeneration in db/db mice | Q46591524 |
| | Longitudinal study of the effects of a high-fat diet on glucose regulation, hippocampal function, and cerebral insulin sensitivity in C57BL/6 mice | Q48380166 |
| | Long-term potentiation enhances neurogenesis in the adult dentate gyrus. | Q48515412 |
| | Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes | Q48603149 |
| | The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease | Q48615135 |
| | Increased Aβ production prompts the onset of glucose intolerance and insulin resistance. | Q48616769 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type 2 diabetes | Q3025883 |
| | neurogenesis | Q1456827 |
| P304 | page(s) | e89229 | |
| P577 | publication date | 2014-02-20 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Central proliferation and neurogenesis is impaired in type 2 diabetes and prediabetes animal models | |
| P478 | volume | 9 | |